Safety issues around misuse of antiepileptics

Expert Opinion on Drug Safety

Volumn 12, Issue 5, 2013, Pages 647-657

  Piskorska, Barbara ^a   Miziak, Barbara ^a   Czuczwar, Stanisław J ^a,b   Borowicz, Kinga K ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Antiepileptic drugs; Epilepsy; Misuse; Nonadherence; Noncompliance

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETHOSUXIMIDE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ANTICONVULSANT THERAPY; COGNITIVE DEFECT; COMMUNICATION DISORDER; COMORBIDITY; CONGENITAL DISORDER; CONGENITAL HEART MALFORMATION; DEMENTIA; DEPRESSION; DRUG FATALITY; DRUG MISUSE; DRUG SAFETY; DRUG USE; EDUCATIONAL STATUS; EPILEPSY; EUPHORIA; HEALTH CARE COST; HOSPITALIZATION; HUMAN; INTRAUTERINE GROWTH RETARDATION; MEDICATION COMPLIANCE; MICROCEPHALY; MIGRAINE; MOOD DISORDER; NEURAL TUBE DEFECT; NEURALGIA; NEUROPATHIC PAIN; PATIENT COMPLIANCE; PREGNANT WOMAN; PREVALENCE; PSYCHOSOCIAL CARE; REVIEW; RISK ASSESSMENT; SUICIDAL IDEATION; TERATOGENICITY; TREATMENT REFUSAL; UNSPECIFIED SIDE EFFECT; UROGENITAL TRACT DISEASE;

ANTICONVULSANTS; EPILEPSY; HEALTH CARE COSTS; HUMANS; MEDICATION ADHERENCE; PRESCRIPTION DRUG MISUSE;

EID: 84882933637     PISSN: 14740338     EISSN: 1744764X     Source Type: Journal    
DOI: 10.1517/14740338.2013.796363     Document Type: Review

References (89)

1. Sabate E. Adherence to long-term therapies: evidence for action. World Health Organization, Geneva; 2003
2. Casati A, Sedefov R, Pfeiffer-Gerschel T. Misuse of medicines in the European union: a systematic review of the literature. Eur Addict Res 2012;18:228-45
3. Donmall M. UK monitoring of problem drug users: the drug misuse database-a system based on regional centres. Eur Addict Res 1999;5:185-90
4. Kaye S, Darke S. The diversion and misuse of pharmaceutical stimulants: what do we know and why should we care? Addiction 2012;107:467-77
5. Nakhutina L, Gonzalez JS, Margolis SA, et al. Adherence to antiepileptic drugs an beliefs about medication among predominantly ethnic minority patients with epilepsy. Epilepsy Behav 2011;22:584-6
6. Glombiewski JA, Nestoriuc Y, Rief W, et al. Medication adherence in the general population. PloS One 2012;7:e50537
7. Cramer JA, Glassman M, Rienzi V. The relationship between poor medication compliance and seizures. Epilepsy Behav 2002;3:338-42
8. Jonikas MA, Mandl KD. Surveillance of medication use: early identification of poor adherence. J Am Med Inform Assoc 2011;19:649-54
9. Davis KL, Candrilli SD, Edin HM. Prevalence and cost of nonadherence with antiepileptic drugs in and adult managed care population. Epilepsia 2008;49:446-54
10. Garnett WR. Antiepileptic drug treatment: outcomes and adherence. Pharmacotherapy 2000;20:191S-9S
11. Leppik IE. Compliance during treatment of epilepsy. Epilepsia 1988;29:S79-84
12. Manjunath R, Davis KL, Candrilli SD, Ettinger AB. Association of antiepileptic drug non adherence with risk of seizures in adults with epilepsy. Epilepsy Behav 2009;14:372-8
13. Ettinger AB, Manjunath R, Candrilli SD, Davis KL. Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy. Epilepsy Behav 2009;14:324-9
14. Faught E, Duh MS, Weiner JR, et al. Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM Study. Neurology 2008;71:1572-8
15. Brown I, Sheeran P, Reuber M. Enhancing antiepileptic drug adherence: a randomized controlled trial. Epilepsy Behav 2009;16:634-9
16. Eatock J, Baker GA. Managing patient adherence and quality of life in epilepsy. Neuropsychiatr Dis Treat 2007;3:117-31
17. Harimanama A, Clavel S, Chivorakul P, et al. Associated factors with adherence to antiepileptic drug in the capital city of Lao PDR. Epilepsy Res 2013;104:158-66
18. Kyngas H. Compliance with health regimens of adolescents with epilepsy. Seizure 2000;9:598-604
19. Hovinga CA, Asato MR, Manjunath R, et al. Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: survey of patients with epilepsy and physicians. Epilepsy Behav 2008;13:316-22
20. Modi AC, Rausch JR, Glauser TA. Patterns of nonadherence to antiepileptic drug therapy in children with newly diagnosed epilepsy. JAMA 2011;305:1669-79
21. Modi AC, Morita DA, Glauser TA. One-month adherence in children with new-onset epilepsy: white-coat compliance does not occur. Pediatrics 2008;121:e961-6
22. Jarvie S, Espie CA, Brodie MJ. The development of a questionnaire to assess knowledge of epilepsy: 1-General knowledge of epilepsy. Seizure 1993;2:179-85
23. Asadi-Pooya AA. Drug compliance of children and adolescents with epilepsy. Seizure 2005;14:393-5
24. Podsadecki TJ, Vrijens BC, Tousset EP, et al. "White coat compliance" limits the reliability of therapeutic drug monitoring in HIV-1-infected patients. HIV Clin Trials 2008;9:238-46
25. Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med 1990;150:1509-10
26. Carpentier N, Jonas J, Frismand S, et al. Direct evidence of nonadherence to antiepileptic medication in refractory focal epilepsy. Epilepsia 2013;54:e20-3
27. Sweileh WM, Ihbesheh MS, Jarar IS, et al. Self-reported medication adherence and treatment satisfaction in patients with epilepsy. Epilepsy Behav 2011;21:301-5
28. Collins NS, Shapiro RA, Ramsay RE. Elders with epilepsy. Med Clin North Am 2006;90:945-66
29. Sheorajpanday RV, De Deyn PP. Epileptic fits and epilepsy in the elderly: general reflections, specific issues and therapeutic implications. Clin Neurol Neurosurg 2007;109:727-43
30. Chen LA, Cheng SJ, Jou SB. Epilepsy in the Elderly. Int J Gerontol 2012;6:63-7
31. Cloyd J, Hauser W, Towne A, et al. Epidemiological and medical aspects of epilepsy in the elderly. Epilepsy Res 2006;68(Suppl 1):s39-48
32. Ettinger AB, Baker GA. Best clinical and research practice in epilepsy of older people: focus on antiepileptic drug adherence. Epilepsy Behav 2009;15(Suppl 1):s60-3
33. Brodie MJ, Kwan P. Epilepsy in elderly people. BMJ 2005;331:1317-22
34. Neufeld MY, Vishne T, Chistik V, Korczyn AD. Life-long history of injuries related to seizures. Epilepsy Res 1999;34:123-7
35. Lackner TE. Strategies for optimizing antiepileptic drug therapy in elderly people. Pharmacotherapy 2002;22:329-64
36. French JA, Staley BA. AED treatment through different ages: as our brains change, should our drug choices also? Epilepsy Curr 2012;12(Suppl 3):22-7
37. Kanner AM, Nieto JC. Depressive disorders in epilepsy. Neurology 1999;53(Suppl 2):S26-32
38. Mula M, Sander JW. Negative effects of antiepileptic drugs on mood in patients with epilepsy. Drug Saf 2007;30:555-67
39. Borthen I, Eide MG, Veiby G, et al. Complications during pregnancy in women with epilepsy: population-based cohort study. BJOG 2009;116:1736-42
40. Tomson T, Battino D, Bonizzoni E, et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011;10:609-17
41. Montouris G. Importance of monotherapy in women across the reproductive cycle. Neurology 2007;69:S10-16
42. Williams J, Myson V, Steward S, et al. Self-discontinuation of antiepileptic medication in pregnancy: detection by hair analysis. Epilepsia 2002;43:824-31
43. Man SL, Petersen I, Thompson M, Nazareth I. Antiepileptic drugs during pregnancy in primary care: a UK population based study. Plos One 2012;7:e52339
44. Matsui D. Adherence with drug therapy in pregnancy. Obstet Gynecol Int 2012;2012:1-5
45. Tomson T, Landmark CJ, Battino D. Antiepileptic drug treatment in pregnancy: changes in drug disposition and their clinical implications. Epilepsia 2013;54:405-14
46. Tomson T, Battino D. Teratogenic effects of antiepileptic drugs. Lancet Neurol 2012;11:803-13
47. Tatum WO. Use of antiepileptic drugs in pregnancy. Expert Rev Neurother 2006;6:1077-86
48. Kulaga S, Sheehy O, Zargarzadeh AH, et al. Antiepileptic drug use during pregnancy: perinatal outcomes. Seizure 2011;20:667-72
49. Adab N, Kini U, Vinten J, et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2004;75:1575-83
50. Pennell PB. The importance of monotherapy in pregnancy. Neurology 2003;60(Suppl4):S31-8
51. Artama M, Auvinen A, Raudaskoski T, et al. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology 2005;64:1874-8
52. Pennell PB. Pregnancy in women who have epilepsy. Neurol Clin 2004;22:799-820
53. Rauchenzauner M, Ehrensberger M, Prieschl M, et al. Generalized tonic-clonic seizure and antiepileptic drugs during pregnancy-a matter of importance for the baby? J Neurol 2012;260:484-8
54. O'Connor SE, Zupanc ML. Women and epilepsy. J Pediatr Pharmacol Ther 2009;14:212-20
55. Khasro I, Rahma S. Drug compliance in epileptic children in Sulaymani Governate. Iraqi Postgr Med J 2010;9:158-62
56. Kyngas H. Predictors of good compliance in adolescents with epilepsy. Seizure 2001;10:549-53
57. Mitchell WG, Scheier LM, Baker SA. Adherence to treatment in children with epilepsy: who follows "doctor's orders"? Epilepsia 2000;41:1616-25
58. Bandstra NF, Camfield CS, Camfield PF. Stigma of epilepsy. Can J Neurol Sci 2008;35:436-40
59. Shore CP, Buelow JM, Austin JK, Johnson CS. Continuing psychosocial care needs in children with new-onset epilepsy and their parents. J Neurosci Nurs 2009;41:244-50
60. Dilorio C, Osborne Shafer P, Letz R, et al. The association of stigma with self-management and perceptions of health care among adults with epilepsy. Epilepsy Behav 2003;4:259-67
61. Helde G, Bovin G, Brather G, et al. A structured, nurse led intervention program improves quality of life in patients with epilepsy: a randomized, controlled trial. Epilepsy Behav 2005;7:451-7
62. Greenhill L, Betts T, Pickard N. The epilepsy nurse specialists- expendable handmaiden or essential colleague? Seizure 2001;10:623-4
63. Mahret-Imhof R, Jaggi S, Bonomo A, et al. Quality of life in adult patients with epilepsy and their family members. Seizure 2013;22:28-35
64. Hovinga CA, Asato MR, Manjunath R, et al. Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: survey of patients with epilepsy and physicians. Epilepsy Behav 2008;13:316-22
65. Muclow JC, Dollery CT. Compliance with anticonvulsant therapy in a hospital clinic and in the community. Br J Clin Pharmacol 1978;6:75-9
66. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001;23:1296-310
67. Haag A, Strzelczyk A, Bauer S, et al. Quality of life and employment status are correlated with antiepileptic monotherapy versus politherapy and not with use of "newer" versus "classic" drugs: results of the "Compliant 2006" survey in 907 patients. Epilepsy Behav 2010;19:618-22
68. Kariyawasam SH, Bandara N, Koralagama A, Senanayake S. Challenging epilepsy with antiepileptic pharmacotherapy in a tertiary teaching hospital in Sri Lanka. Neurol India 2004;52:233-7
69. Arlt S, Lindner R, Rosler A, von Renteln-Kruse W. Adherence to medication in patients with dementia: predictors and strategies for improvement. Drugs Aging 2008;25:1033-47
70. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: metaanalysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160:2101-7
71. Chen HF, Tsai YF, Lin YP, et al. The relationship among medicine symptom distress, selfefficacy, patient-provider relationship, and medication compliance in patients with epilepsy. Epilepsy Behav 2010;19:43-9
72. Fraser RT, Johnson EK, Miller JW, et al. Managing epilepsy well: self - management needs assessment. Epilepsy Behav 2011;20:291-8
73. Modi AC, Wu YP, Guilfoyle SM, Glauser TA. Uninformed clinical decisions resulting from lack of adherence assessment in children with new-onset epilepsy. Epilepsy Behav 2012;25:484
74. Bautista RE, Rundle-Gonzalez V. Effects of antiepileptic drug characteristics on medication adherence. Epilepsy Behav 2012;23:437-41
75. Smithson WH, Hukins D, Colwell B, Mathers N. Developing a method to identify medicines non-adherence in a community sample of adults with epilepsy. Epilepsy Behav 2012;24:49-53
76. Faught E. Adherence to antiepilepsy drug therapy. Epilepsy Behav 2012;25:297-302
77. Faught RE, Weiner JR, Guerin A, et al. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study. Epilepsia 2009;50:501-9
78. Jones RM, Butler JA, Thomas VA, et al. Adherence to treatment in patients with epilepsy: associations with seizure control and illness beliefs. Seizure 2006;15:504-8
79. Johannessen Landmark C, Larsson PG, Rytter E, Johannessen SI. Antiepileptic drugs in epilepsy and other disorders-a population-based study of prescriptions. Epilepsy Res 2009;87:31-9
80. Mondon S, Nogue S, Urbano D, Rovira E. [Gabapentin abuse].[Article in Spanish]. Med Clin (Barc) 2010;134:138-9
81. Grosshans M, Mutschler J, Hermann D, et al. Pregabalin abuse, dependence, and with-drawal: a case report. Am J Psychiatry 2010;167:869
82. Webb J. Gabapentin-another drug of misuse? BCPhA Tablet 2008;17:12-13
83. Scott J, Pope M. Nonadherence with mood stabilizers: prevalence and predictors. J Clin Psychiatry 2002;63:384-90
84. Sajatovic M, Valenstein M, Blow F, et al. Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder. Psychiatr Serv 2007;58:855-63
85. Frauger E, Pauly V, Pradel V, et al. Evidence of clonazepam abuse liability: results of the tools developed by the French Centers for Evaluation and Information on Pharmacodependence (CEIP) network. Fundam Clin Pharmacol 2011;25:633-41
86. Filipetto FA, Zipp CP, Coren JS. Potential for pregabalin abuse or diversion after past drug-seeking behavior. J Am Osteopath Assoc 2010;110:605-7
87. Schifano F, D'Offizi S, Piccione M, et al. Is there a recreational misuse potential for pregabalin? Analysis of anecdotal online reports in comparison with related gabapentin and clonazepam data. Psychother Psychosom 2011;80:118-22
88. Sinha S, Siddiqui KA. Definition of intractable epilepsy. Neurosciences (Riyadh) 2011;16:3-9
89. Liu L, Yiu CH, Yen DJ, et al. Medication education for patients with epilepsy in Taiwan. Seizure 2003;12:473-7